These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 18834855)
1. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Luan S; Sun L; Huang F Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934 [TBL] [Abstract][Full Text] [Related]
3. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223 [TBL] [Abstract][Full Text] [Related]
4. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Kojima K; Ohhashi R; Fujita Y; Hamada N; Akao Y; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2008 Aug; 373(3):423-8. PubMed ID: 18573234 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213 [TBL] [Abstract][Full Text] [Related]
8. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Li J; Chen Y; Zhao J; Kong F; Zhang Y Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697 [TBL] [Abstract][Full Text] [Related]
9. The miR-34 family in cancer and apoptosis. Hermeking H Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653 [TBL] [Abstract][Full Text] [Related]
10. p53 enters the microRNA world. Hermeking H Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645 [TBL] [Abstract][Full Text] [Related]
11. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876 [TBL] [Abstract][Full Text] [Related]
12. E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis. Lizé M; Pilarski S; Dobbelstein M Cell Death Differ; 2010 Mar; 17(3):452-8. PubMed ID: 19960022 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Audrito V; Vaisitti T; Rossi D; Gottardi D; D'Arena G; Laurenti L; Gaidano G; Malavasi F; Deaglio S Cancer Res; 2011 Jul; 71(13):4473-83. PubMed ID: 21565980 [TBL] [Abstract][Full Text] [Related]
16. The microRNA profile of prostate carcinoma obtained by deep sequencing. Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999 [TBL] [Abstract][Full Text] [Related]
17. Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site. Feinberg-Gorenshtein G; Avigad S; Jeison M; Halevy-Berco G; Mardoukh J; Luria D; Ash S; Steinberg R; Weizman A; Yaniv I Genes Chromosomes Cancer; 2009 Jul; 48(7):539-43. PubMed ID: 19373781 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Li T; Li D; Sha J; Sun P; Huang Y Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]